402856-42-2
- Product Name：Tesofensine powder
- Molecular Formula：C17H23NCl2O
- Purity：99%
- Molecular Weight：0
Product Details;
CasNo： 402856-42-2
Molecular Formula： C17H23NCl2O
Quality Factory Supply Tesofensine powder, Factory Sells 402856-42-2 Safe Shipping
- Molecular Formula:C17H23NCl2O
- Molecular Weight:0
- Vapor Pressure:0mmHg at 25°C
- Refractive Index:1.539
- Boiling Point:396.629 °C at 760 mmHg
- Flash Point:193.675 °C
- PSA：12.47000
- Density:1.162 g/cm3
- LogP:4.53410
Tesofensine(Cas 402856-42-2) Usage
| Description | Tesofensine is a serotonin–noradrenaline–dopamine reuptake inhibitor belonging to the phenyltropane family of drugs, and it is currently under development for the treatment of obesity. Originally developed by the Danish biotechnology company NeuroSearch, the rights to Tesofensine were transferred to Saniona in 2014. As a potential anti-obesity medication, Tesofensine has shown positive effects in patients, including a reduction in appetite sensations within 14 days of treatment. Those undergoing treatment reported increased feelings of satiety and a decreased desire to eat. Additionally, Tesofensine has demonstrated a significant increase in fat oxidation and a reduction in fat tissue, making it a subject of interest in the ongoing exploration of obesity treatment options. |
|
Uses |
Tesofensine, is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is currently in clinical development for the treatment of obesity. |
InChI:InChI=1/C17H23Cl2NO/c1-3-21-10-14-13(9-12-5-7-17(14)20(12)2)11-4-6-15(18)16(19)8-11/h4,6,8,12-14,17H,3,5,7,9-10H2,1-2H3/t12?,13-,14-,17?/m1/s1
Relevant Products
-
Toremifene CitrateCAS：89778-27-8
-
Spermidine TrihydrochlorideCAS：334-50-9
-
2-PhenylpiperidinehydrochlorideCAS：3466-81-7
